“…Since the advent of the Coronavirus Disease 2019 (COVID-19) pandemic, dominated by respiratory disease and evolution of acute respiratory distress syndrome (ARDS), cardiovascular compromise, excessive systemic inflammation and coagulopathy in adults [ 1 , 2 , 3 ], several countries affected by the coronavirus disease [ 4 ] pandemic have reported an unusually high number of cases of children hospitalized due to a multisystem inflammatory condition, at times requiring intensive care ( Table S1 ) [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 ]. The Royal College of Paediatrics and Child Health (RCPCH) defined a paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) [ 34 ], and the Centers for Disease Control and Prevention (CDC) defined a multisystem inflammatory syndrome in children (MIS-C) [ 35 ], detailed in Table S2 .…”